BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 22256786)

  • 1. The six-minute walk test using forehead oximetry is reliable in the assessment of scleroderma lung disease.
    Wilsher M; Good N; Hopkins R; Young P; Milne D; Gibson A; Suppiah R; Ly J; Doughty R; Dalbeth N
    Respirology; 2012 May; 17(4):647-52. PubMed ID: 22256786
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Correlation of the degree of dyspnea with health-related quality of life, functional abilities, and diffusing capacity for carbon monoxide in patients with systemic sclerosis and active alveolitis: results from the Scleroderma Lung Study.
    Khanna D; Clements PJ; Furst DE; Chon Y; Elashoff R; Roth MD; Sterz MG; Chung J; FitzGerald JD; Seibold JR; Varga J; Theodore A; Wigley FM; Silver RM; Steen VD; Mayes MD; Connolly MK; Fessler BJ; Rothfield NF; Mubarak K; Molitor J; Tashkin DP;
    Arthritis Rheum; 2005 Feb; 52(2):592-600. PubMed ID: 15692967
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Limitations to the 6-minute walk test in interstitial lung disease and pulmonary hypertension in scleroderma.
    Garin MC; Highland KB; Silver RM; Strange C
    J Rheumatol; 2009 Feb; 36(2):330-6. PubMed ID: 19208563
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Six-minute walk test for the evaluation of pulmonary disease severity in scleroderma patients.
    Villalba WO; Sampaio-Barros PD; Pereira MC; Cerqueira EM; Leme CA; Marques-Neto JF; Paschoal IA
    Chest; 2007 Jan; 131(1):217-22. PubMed ID: 17218579
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Performance capacity evaluated using the 6-minute walk test: 5-year results in patients with diffuse systemic sclerosis and initial interstitial lung disease.
    Rizzi M; Sarzi-Puttini P; Airoldi A; Antivalle M; Battellino M; Atzeni F
    Clin Exp Rheumatol; 2015; 33(4 Suppl 91):S142-7. PubMed ID: 26339893
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Assessment of functional capacity in patients with chronic obstructive pulmonary disease: correlation between cardiopulmonary exercise, 6 minute walk and 15 step exercise oximetry test.
    Starobin D; Kramer MR; Yarmolovsky A; Bendayan D; Rosenberg I; Sulkes J; Fink G
    Isr Med Assoc J; 2006 Jul; 8(7):460-3. PubMed ID: 16889159
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Validity of the Saint George's Respiratory Questionnaire in the evaluation of the health-related quality of life in patients with interstitial lung disease secondary to systemic sclerosis.
    Beretta L; Santaniello A; Lemos A; Masciocchi M; Scorza R
    Rheumatology (Oxford); 2007 Feb; 46(2):296-301. PubMed ID: 16877463
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Quantitative 15 steps exercise oximetry as a marker of disease severity in patients with chronic obstructive pulmonary disease.
    Kramer MR; Krivoruk V; Lebzelter J; Liani M; Fink G
    Isr Med Assoc J; 1999 Nov; 1(3):165-8. PubMed ID: 10731326
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of the functional parameters in scleroderma cases with pulmonary involvement.
    Celebi Sözener Z; Karabıyıkoğlu G; Düzgün N
    Tuberk Toraks; 2010; 58(3):235-41. PubMed ID: 21038133
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Preliminary report of the 6-minute walk test as a predictor of radiation-induced pulmonary toxicity.
    Miller KL; Kocak Z; Kahn D; Zhou SM; Baydush A; Hollis D; Folz RJ; Tisch A; Clough R; Yu X; Light K; Marks LB
    Int J Radiat Oncol Biol Phys; 2005 Jul; 62(4):1009-13. PubMed ID: 15990002
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The body weight-walking distance product as related to lung function, anaerobic threshold and peak VO2 in COPD patients.
    Chuang ML; Lin IF; Wasserman K
    Respir Med; 2001 Jul; 95(7):618-26. PubMed ID: 11453321
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Six minute walk test Z score: correlations with cystic fibrosis severity markers.
    Stollar F; Rodrigues JC; Cunha MT; Leone C; Adde FV
    J Cyst Fibros; 2012 May; 11(3):253-6. PubMed ID: 22188977
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Six-minute walking test in cystic fibrosis adults with mild to moderate lung disease: comparison to healthy subjects.
    Chetta A; Pisi G; Zanini A; Foresi A; Grzincich GL; Aiello M; Battistini A; Olivieri D
    Respir Med; 2001 Dec; 95(12):986-91. PubMed ID: 11778797
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Exercise testing in severe emphysema: association with quality of life and lung function.
    Brown CD; Benditt JO; Sciurba FC; Lee SM; Criner GJ; Mosenifar Z; Shade DM; Slivka WA; Wise RA;
    COPD; 2008 Apr; 5(2):117-24. PubMed ID: 18415810
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lack of specificity of the 6-minute walk test as an outcome measure for patients with systemic sclerosis.
    Schoindre Y; Meune C; Dinh-Xuan AT; Avouac J; Kahan A; Allanore Y
    J Rheumatol; 2009 Jul; 36(7):1481-5. PubMed ID: 19487260
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Severity of scleroderma lung disease is related to alveolar concentration of nitric oxide.
    Tiev KP; Cabane J; Aubourg F; Kettaneh A; Ziani M; Mouthon L; Duong-Quy S; Fajac I; Guillevin L; Dinh-Xuan AT
    Eur Respir J; 2007 Jul; 30(1):26-30. PubMed ID: 17428812
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Repeatability of the six-minute walk test and relation to physical function in survivors of a critical illness.
    Alison JA; Kenny P; King MT; McKinley S; Aitken LM; Leslie GD; Elliott D
    Phys Ther; 2012 Dec; 92(12):1556-63. PubMed ID: 22577064
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reduced exercise capacity in systemic sclerosis patients without pulmonary involvement.
    de Oliveira NC; dos Santos Sabbag LM; Ueno LM; de Souza RB; Borges CL; de Sá Pinto AL; Lima FR
    Scand J Rheumatol; 2007; 36(6):458-61. PubMed ID: 18092268
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Relationship between left ventricular diastolic dysfunction and six minute walk test in patients with systemic sclerosis.
    Akdogan A; Kaya EB; Sahin A; Okutucu S; Yakut E; Kalyoncu U; Aksoy H; Karadag O; Calguneri M; Tokgozoglu L; Kiraz S; Ertenli I
    Int J Rheum Dis; 2011 Oct; 14(4):379-83. PubMed ID: 22004236
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association of six-minute walk distance (6MWD) with resting pulmonary function in patients with chronic obstructive pulmonary disease (COPD).
    Fujimoto H; Asai K; Watanabe T; Kanazawa H; Hirata K
    Osaka City Med J; 2011 Jun; 57(1):21-9. PubMed ID: 22106764
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.